- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 1, 2026 | 2.64M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 492K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 6K sh |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$25.99M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $1.21M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $500.08M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $509.77M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $15.79M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $15.44M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $19.77M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $256.06M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $265.36M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $535.49M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $592.94M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $792.32M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $859.19M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$70.52 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$1,983.00 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$70.52 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$1,983.00 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $2.03M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $2.18M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$8.31M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$6.11M |
| Revenue | Q1 2026 · Mar 31, 2026 | $11.88M |
| Revenue | Q1 2026 · Mar 31, 2025 | $12.13M |